Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Peptide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... investments and substantial funding for genomics and proteomics research are driving the demand for peptides in drug discovery and therapeutic development. Owing to the rising demand for effective protein-based drugs for the proper treatment process, ... Read More
-
Drug Discovery Informatics
... at a CAGR of 9.6% over the analysis period 2024-2030. Drug Discovery Informatics Software, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.4 Billion by the ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Peptide Synthesis Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More
-
Label-free Array Systems
... at a CAGR of 5.6% over the analysis period 2024-2030. Surface Plasmon Resonance (SPR) Technology, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.8 Billion by ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
Pathology Instruments
... CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Organs-on-Chips
... 35.3% over the analysis period 2024-2030. Liver-on-a- Chip, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth ... Read More
-
Single-Use Bioprocessing
... CAGR of 20.8% over the analysis period 2024-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by the end ... Read More
-
MRSA Drugs
... CAGR of 4.5% over the analysis period 2024-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end of the ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Hepatitis C Treatment
... at a CAGR of 10.7% over the analysis period 2024-2030. HCV Protease Inhibitors, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$25.3 Billion by the end ... Read More
-
Fragment-based Drug Discovery
... at a CAGR of 8.8% over the analysis period 2024-2030. Fragment Screening Technology, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Small Molecule Drug Discovery
... 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$24.9 Billion by ... Read More
-
Antivirals Drug
... CAGR of 4.2% over the analysis period 2024-2030. DNA Polymerase Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$14.7 Billion by the end of the ... Read More
-
Stable Isotope Labeled Compounds
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Deuterium, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$183.4 Million by the end ... Read More
-
Global Preclinical Software Market for Physiology DA and AS 2025-2029
... the forecast period. The report on the preclinical software for physiology DA and AS market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around ... Read More
-
Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029
... like oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is a major growth driver. Moreover, improved bioinformatics tools for data analysis and interpretation are enhancing the usability of NGS, driving its widespread adoption. “The ... Read More
-
Biotechnology Market in US 2025-2029
... market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
... 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major ... Read More
-
Global Janus Kinase (JAK) Inhibitors Market - 2024-2032
... of 8.4% during the forecast period 2024-2032. Pipeline Drugs Janus kinase is a group of proteins that are involved in the cytokine signaling pathway. These are known to play a crucial role in several autoimmune, ... Read More
-
Organs-on-Chips Market by Type of Product (organ based and disease based), Type of Organ (single organ based and multi organ based), Type of Single Organ based Model (liver, lung, brain, heart, intestine, kidney and other organs), Type of Material of Construction (polydimethylsiloxane, other polymer, glass and others), Purpose (research and therapeutic), Application Area (drug discovery / toxicity testing, cancer research, stem cell research, tissue engineering / regenerative medicine and others), End User (pharmaceutical and biotech companies, academic and research players, cosmetic industry players and other end users), Key Geographical Regions and Leading Players: Industry Trends and Global Forecasts, Till 2035
... of 25. 6% during the forecast period, till 2035. The opportunity for organ on a chip market has been distributed across the following segments: Type of Product Organ based Disease based Type of Organ Single ... Read More
-
Metaverse in Healthcare Market by Component (Software, Hardware and Services), Type of Technology (Augmented Reality / Virtual Reality, Artificial Intelligence, Blockchain Technology, Mixed Reality and Other Technologies), Applications (Telehealth, Medical Training and Education, Drug Discovery and Personalized Medicine, Diagnosis, and Other Applications), End Users (MedTech Companies, Healthcare Providers, Biopharmaceutical, Biotechnology and Life Sciences Companies, Payers, and Patients), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America) and Key Players: Industry Trends and Global Forecasts, Till 2035
... at a CAGR of 31. 1% during the forecast period, till 2035. The opportunity for metaverse in healthcare market has been distributed across the following segments: Type of Technology Augmented Reality / Virtual Reality Artificial ... Read More
-
Bioprocess Containers Global Market Report 2025
... Biotech S.A.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Sartorius AG Bioprocess Containers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Cancer Immunotherapy Global Market Report 2025
... Cancer Research Centers; ClinicsCovering: Amgen Inc.; AstraZeneca PLC; F. Hoffmann-La Roche Ltd; Bayer AG; Eli Lilly and Company Cancer Immunotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management ... Read More